Illumina defends its board, calls Icahn campaign ‘character assassination’
The activist investor’s plan shows a lack of understanding of the company and genomics industry, the maker of DNA sequencers said.
Illumina defends its board, calls Icahn campaign ‘character assassination’ Read More »
